Cargando…
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
Identifying novel circulating biomarkers predictive of response and informative about the mechanisms of resistance, is the new challenge for breast cancer (BC) management. The integration of omics information will gradually revolutionize the clinical approach. Liquid biopsy is being incorporated int...
Autores principales: | Gianni, Caterina, Palleschi, Michela, Merloni, Filippo, Di Menna, Giandomenico, Sirico, Marianna, Sarti, Samanta, Virga, Alessandra, Ulivi, Paola, Cecconetto, Lorenzo, Mariotti, Marita, De Giorgi, Ugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695769/ https://www.ncbi.nlm.nih.gov/pubmed/36430675 http://dx.doi.org/10.3390/ijms232214197 |
Ejemplares similares
-
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer
por: Gianni, Caterina, et al.
Publicado: (2022) -
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
por: Merloni, Filippo, et al.
Publicado: (2023) -
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment
por: Gianni, Caterina, et al.
Publicado: (2022) -
Oligometastatic breast cancer and metastasis-directed treatment: an
aggressive multimodal approach to reach the cure
por: Merloni, Filippo, et al.
Publicado: (2023) -
Moving beyond PARP Inhibition: Current State and Future Perspectives in Breast Cancer
por: Palleschi, Michela, et al.
Publicado: (2021)